Minimal residual disease-directed therapy in acute myeloid leukemia
Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR),
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 January 2015
|
| In: |
Blood
Year: 2015, Volume: 125, Issue: 15, Pages: 2331-2335 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2014-11-578815 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2014-11-578815 Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/125/15/2331 
|
| Author Notes: | Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter |
| Summary: | Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR), |
|---|---|
| Item Description: | Gesehen am 11.07.2017 |
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2014-11-578815 |